Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 7/20 | 0.59 |
| ▸ | NAAA | Q02083 | 2/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10879403 | 0.85 | EPHX1 (0.65) | EPHX2NAAAEPHX1GAAKMT2A | |
| Hydrochloric Acid SCHEMBL4446983 | 0.83 | EPHX1 (0.54) | EPHX2NAAAEPHX1GAAKMT2A | |
| SCHEMBL14703637 | 0.83 | EPHX1 (0.62) | EPHX2NAAAEPHX1GAATSHR | |
| SCHEMBL27905835 | 0.82 | NAAA (0.75) | EPHX2NAAAEPHX1TSHRLMNA | |
| SCHEMBL21059247 | 0.81 | EPHX1 (0.65) | EPHX2NAAAEPHX1GAATSHR | |
| SCHEMBL15975473 | 0.81 | EPHX1 (0.65) | EPHX2NAAAEPHX1GAATSHR | |
| SCHEMBL16374741 | 0.81 | EPHX1 (0.64) | EPHX2NAAAEPHX1GAA | |
| SCHEMBL12635064 | 0.81 | EPHX1 (0.55) | EPHX2NAAAEPHX1GAA | |
| SCHEMBL11323558 | 0.80 | NAAA (0.72) | EPHX2NAAAEPHX1TSHRLMNA | |
| SCHEMBL12991745 | 0.80 | EPHX1 (0.67) | EPHX2NAAAEPHX1GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125757-A1 | MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS | Novartis AG (CH) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008101665-A1 | MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS | NOVARTIS AG (CH) | 2008-08-28 | — | — | WO | disclosed |